Medical treatment in primary and secondary hyperparathyroidism.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001847:Bone Diseases / Q000150:complications / Q000000981:diagnostic imaging; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D006996:Hypocalcemia / Q000209:etiology; D007674:Kidney Diseases / Q000150:complications; D010018:Osteomalacia / Q000209:etiology; D010280:Parathyroid Glands / Q000601:surgery; D010710:Phosphates / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D008926:Plicamycin / Q000627:therapeutic use; D011547:Pseudohypoparathyroidism / Q000150:complications; D011859:Radiography; D006435:Renal Dialysis; D014511:Uremia / Q000209:etiology; D014807:Vitamin D / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D010710:Phosphates; D014807:Vitamin D; D002116:Calcitonin; D008926:Plicamycin; D002118:Calcium